FDA Drug Application (090541) for TRI-LO-LINYAH by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number090541
Product Number001
FormTABLET; ORAL
Dosage0.18MG; 0.025MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRI-LO-LINYAH
Active IngredientNORGESTIMATE; ETHINYL ESTRADIOL



Back to FDA Applications sponsored by NOVAST LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.